Food and Drug Administration (FDA)
2022
- 01-28-2022
- Independent Attestation Report: Food and Drug Administration Budget Formulation Compliance Report and Detailed Accounting Submission for Fiscal Year 2021 National Drug Control Activities, and Accompanying Required Assertions A-03-22-00352
2021
- 12-16-2021
- The Food and Drug Administration Needs To Improve Its Contract Closeout Processes To Identify Contracts Eligible for Closeout and Close Contracts Timely A-03-20-03004
- 05-07-2021
- Risk Assessment of the Food and Drug Administration's Travel Card Program A-04-19-06235
2020
- 09-30-2020
- Risk Assessment of Food and Drug Administration's Purchase Card Program A-04-19-06234
2019
- 08-20-2019
- The Food and Drug Administration Did Not Submit Clearance Documents for Any Audit Recommendations During Fiscal Years 2015 and 2016 but Has Since Made Significant Progress (A-07-18-03231)
- 06-26-2019
- The Food and Drug Administration Generally Complied With Federal Requirements for the Preparation and Receipt of Select Agent Shipments (A-03-16-00354)
2018
- 10-29-2018
- The Food and Drug Administration's Policies and Procedures Should Better Address Postmarket Cybersecurity Risk to Medical Devices (A-18-16-30530)
- 06-04-2018
- The Food and Drug Administration Computed Prescription Drug User Fee Rates Accurately (A-05-17-00040)